(E)-2-(3,5-Dimethoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

methyl 3-chloro-6-methyl-1-benzothiophene-2-carboxylate, 95.0%, 5g

5-Bromo-2-(piperidin-1-yl)-3-(trifluoromethyl)pyridine, 97%, 5g

Dichloromethane D2, 99.8 at%D, 10 ml, glass packaging

3-Methoxymethyl-phenylamine, 95.0%, 5g

1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid, 95.0%, 10g

1-{4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidin-1-yl}ethan-1-one, %, 1g

3,5-DICHLORO-4-METHOXYBENZALDEHYDE, 95.0%, 10g

2-(Benzylthio)-2-methylpropanoic acid, 97%, 1g

4-Nitroimidazole>98.0%(GC)500g

1-(4-nitrobenzoyl)piperidine-4-carboxylic acid, 95.0%, 1g

2-(2,4,6-trichlorophenoxy)acetohydrazide, 1g

N,N,N',N'',N''-Pentamethyldiethylenetriamine>99.0%(GC)(T)500mL